Mediterranean Fever (MEFV) Peptide
MEFV
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all MEFV products
- MEFV (Mediterranean Fever (MEFV))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-MEFV antibody (Catalog #: ARP32016_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- MEFV (Mediterranean Fever (MEFV))
- Background
-
MEFV was identified as the gene that when mutated causes Mediterranean fever, a hereditary periodic fever syndrome. MEFV is expressed in granulocytes and myeloid bone marrow precursors.
Alias Symbols: FMF, MEF, TRIM20
Protein Interaction Partner: COG5,PSTPIP1,PYCARD,COG5,PYCARD
Protein Size: 781 - Molecular Weight
- 86 kDa
- Gene ID
- 4210
- NCBI Accession
- NM_000243, NP_000234
- UniProt
- O15553
-
You are here:
